PE20071311A1 - Compuestos 8-azabiciclo[3.2.1]octano como antagonistas del receptor opioide mu - Google Patents

Compuestos 8-azabiciclo[3.2.1]octano como antagonistas del receptor opioide mu

Info

Publication number
PE20071311A1
PE20071311A1 PE2007000212A PE2007000212A PE20071311A1 PE 20071311 A1 PE20071311 A1 PE 20071311A1 PE 2007000212 A PE2007000212 A PE 2007000212A PE 2007000212 A PE2007000212 A PE 2007000212A PE 20071311 A1 PE20071311 A1 PE 20071311A1
Authority
PE
Peru
Prior art keywords
azabicycle
alkyl
compounds
octane
antagonists
Prior art date
Application number
PE2007000212A
Other languages
English (en)
Inventor
Daniel D Long
Lan Jiang
Timothy J Church
John R Jacobsen
Daisuke Roland Saito
Dyke Priscilla M Van
Ioanna Stergiades
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38436795&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20071311(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of PE20071311A1 publication Critical patent/PE20071311A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

REFERIDA A UN COMPUESTO 8-AZABICICLO[3.2.1]OCTANO DE FORMULA (I), DONDE R1 ES ORa, C(O)NRaRb, NHS(O)2Rc, CH2OH, ENTRE OTROS; A ES ALQUILENILO C1-C4; R2 ES CICLOALQUILO C3-C12 O ARILO C6-C10, OPCIONALMENTE SUSTITUIDOS CON ORa, HALO, ALQUILO C1-C3, ENTRE OTROS; G ES ALQUILENILO C1-C4; R3 ES H, C(O)R4, S(O)2Rc, ENTRE OTROS; R4 ES CICLOALQUILO C3-C6, ALQUILO C1-C6, ENTRE OTROS; Ra Y Rb SON H O ALQUILO C1-C4; Rc ES ALQUILO C1-C3. SON COMPUESTOS PREFERIDOS: 3-ENDO-(8-{2-[CICLOHEXILMETIL-(2-HIDROXIACETIL)-AMINO]ETIL}-8-AZABICICLO[3.2.1]OCT-3-IL)-BENZAMIDA, 3-ENDO-(8-{2.[BENCIL-(2-HIDROXIACETIL)-AMINO]ETIL}-8-AZABICICLO[3.2.1]OCT-3-IL)-BENZAMIDA, 3-ENDO-(8-{2-[CICLOHEXILMETIL-((S)-2,3-DIHIDROXI-PROPIONIL)AMINO]ETIL}-8-AZABICILO[3.2.1]OCT-3-IL)-BENZAMIDA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR OPIOIDE MU Y SON UTILES EN EL TRATAMIENTO DE TRASTORNOS GASTROINTESTINALES, DISFUNCION INTESTINAL INDUCIDA POR OIPIOIDES, ENTRE OTROS
PE2007000212A 2006-03-01 2007-02-28 Compuestos 8-azabiciclo[3.2.1]octano como antagonistas del receptor opioide mu PE20071311A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77796206P 2006-03-01 2006-03-01
US84102806P 2006-08-30 2006-08-30

Publications (1)

Publication Number Publication Date
PE20071311A1 true PE20071311A1 (es) 2007-12-29

Family

ID=38436795

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000212A PE20071311A1 (es) 2006-03-01 2007-02-28 Compuestos 8-azabiciclo[3.2.1]octano como antagonistas del receptor opioide mu

Country Status (25)

Country Link
US (11) US7622508B2 (es)
EP (1) EP2001876B1 (es)
JP (2) JP5086280B2 (es)
KR (1) KR101376479B1 (es)
AR (1) AR059690A1 (es)
AT (1) ATE509928T1 (es)
AU (1) AU2007224213B2 (es)
BR (1) BRPI0708490B8 (es)
CA (1) CA2646409C (es)
CY (1) CY1111747T1 (es)
DK (1) DK2001876T3 (es)
HK (1) HK1125935A1 (es)
HR (1) HRP20110590T1 (es)
IL (1) IL193690A (es)
MA (1) MA30284B1 (es)
MX (1) MX2008011165A (es)
MY (1) MY145633A (es)
NZ (1) NZ570764A (es)
PE (1) PE20071311A1 (es)
PL (1) PL2001876T3 (es)
PT (1) PT2001876E (es)
RU (1) RU2423362C2 (es)
SI (1) SI2001876T1 (es)
TW (1) TWI379832B (es)
WO (1) WO2007103187A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TWI409067B (zh) * 2007-02-28 2013-09-21 Theravance Inc ８-氮雜雙環〔３．２．１〕辛烷化合物之結晶型
TWI415850B (zh) * 2007-07-20 2013-11-21 Theravance Inc 製備ｍｕ類鴉片受體拮抗劑之中間物的方法
WO2009029253A1 (en) * 2007-08-27 2009-03-05 Theravance, Inc. Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
ES2390195T3 (es) * 2007-08-27 2012-11-07 Theravance, Inc. Compuestos de amidoalquil-8-azabiciclo(3,2,1)octano, como antagonistas del receptor opioide mu
EP2195314B1 (en) * 2007-08-27 2011-03-23 Theravance, Inc. Disubstituted alkyl-8-azabicyclo [3.2.1.]octane compounds as mu opioid receptor antagonists
TWI423801B (zh) * 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之８－氮雜雙環〔３．２．１〕辛基－２－羥基苯甲醯胺化合物
TW201118084A (en) * 2009-09-18 2011-06-01 Adolor Corp The use of an opioid receptor antagonist for the treatment or prevention of gastrointestinal tract disorders
US20120122928A1 (en) 2010-08-11 2012-05-17 Bayer Cropscience Ag Heteroarylpiperidine and -Piperazine Derivatives as Fungicides
EP2423210A1 (de) 2010-08-25 2012-02-29 Bayer CropScience AG Heteroarylpiperidin- und -piperazinderivate als Fungizide
US8759527B2 (en) 2010-08-25 2014-06-24 Bayer Cropscience Ag Heteroarylpiperidine and -piperazine derivatives as fungicides
WO2012055837A1 (de) 2010-10-27 2012-05-03 Bayer Cropscience Ag Heteroarylpiperidin und -piperazinderivate als fungizide
JP5703009B2 (ja) * 2010-12-16 2015-04-15 住友精化株式会社 スルホン化合物、スルホン化合物の製造方法、および電気化学デバイス用電解液
BR112013019667B1 (pt) 2011-02-01 2019-07-02 Bayer Intellectual Property Gmbh Compostos derivados de heteroaril-piperidina e -piperazina, seus usos, composição, processos de produção de compostos e de composições, método para o controle de fungos fitopatogênicos prejudiciais
MX355824B (es) 2011-09-15 2018-05-02 Bayer Ip Gmbh Piperidinpirazoles como fungicidas.
CN107266382B (zh) 2011-12-27 2020-10-27 拜耳知识产权有限责任公司 作为杀菌剂的杂芳基哌啶和杂芳基哌嗪衍生物
US9192570B2 (en) 2013-12-20 2015-11-24 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
ME03671B (me) * 2015-04-02 2020-10-20 Theravance Biopharma R&D Ip Llc Kombinovani oblik doze antagonista mu opioidnog receptora i opioidni agens
WO2019152946A1 (en) 2018-02-05 2019-08-08 Alkermes, Inc. Compounds for the treatment of pain
IL302671A (en) * 2020-11-06 2023-07-01 Actinogen Medical Ltd A process for the preparation of heterocyclic methane compounds and their aza-bicyclo intermediates

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1067824B (de) * 1954-10-20 1959-10-29 Sandoz Ag Verfahren zur Herstellung saeureamidartiger Tropanabkoemmlinge
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
US6900228B1 (en) * 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
GB9810671D0 (en) * 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
TWI244481B (en) * 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
GB9912410D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US6469030B2 (en) * 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
US20030181447A1 (en) * 2001-02-22 2003-09-25 Boyd Robert E. 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
BR0108965A (pt) 2000-03-03 2002-11-26 Ortho Mcneil Pharm Inc Derivados de 3-(diarilmetileno)-8-azabiciclo[3,2,1]octano
US20020025948A1 (en) * 2000-06-23 2002-02-28 Banks Bernard Joseph 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
US7375115B2 (en) * 2001-10-09 2008-05-20 Kyorin Pharmaceutical Co., Ltd. 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
SI1440059T1 (sl) * 2001-10-22 2008-08-31 Pfizer Prod Inc Derivati 3-azabiciklo(3.1.0)heksana kot antagonisti opioidnega receptorja
US7381721B2 (en) * 2003-03-17 2008-06-03 Adolor Corporation Substituted piperidine compounds
JP3984281B2 (ja) * 2003-04-14 2007-10-03 ファイザー・プロダクツ・インク ３−アザビシクロ〔３，２，１〕オクタン誘導体
US7056930B2 (en) * 2003-04-14 2006-06-06 Pfizer Inc. 2-Azabicyclo[3.3.1]nonane derivatives
US20040204453A1 (en) * 2003-04-14 2004-10-14 Pfizer Inc 4-Phenyl-piperidine compounds and their use as modulators of opioid receptors
BRPI0409570A (pt) * 2003-04-15 2006-04-18 Pfizer Prod Inc derivados de 3-benzidrilideno-8-aza-biciclo[3.2.1]octano com atividade receptora de opióides
US6992090B2 (en) * 2003-06-16 2006-01-31 Adolor Corporation Substituted piperidine compounds and methods of their use
US7435822B2 (en) 2004-02-03 2008-10-14 Janssen Pharmaceutica N.V. 3-(diheteroarylmethylene)-8-azabicyclo[3.2.1]octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3.2.1]octane derivatives
US7087749B2 (en) * 2004-03-11 2006-08-08 Adolor Corporation Substituted piperidine compounds and methods of their use
US7538110B2 (en) * 2005-10-27 2009-05-26 Adolor Corporation Opioid antagonists
MY145633A (en) * 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
EP2097083A2 (en) 2006-11-07 2009-09-09 Nektar Therapeutics AL, Corporation Dosage forms and co-administration of an opioid agonist and an opioid antagonist
TWI409067B (zh) 2007-02-28 2013-09-21 Theravance Inc ８-氮雜雙環〔３．２．１〕辛烷化合物之結晶型
TWI415850B (zh) * 2007-07-20 2013-11-21 Theravance Inc 製備ｍｕ類鴉片受體拮抗劑之中間物的方法
WO2009029253A1 (en) 2007-08-27 2009-03-05 Theravance, Inc. Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
EP2195314B1 (en) 2007-08-27 2011-03-23 Theravance, Inc. Disubstituted alkyl-8-azabicyclo [3.2.1.]octane compounds as mu opioid receptor antagonists
ES2390195T3 (es) * 2007-08-27 2012-11-07 Theravance, Inc. Compuestos de amidoalquil-8-azabiciclo(3,2,1)octano, como antagonistas del receptor opioide mu
TWI423801B (zh) 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之８－氮雜雙環〔３．２．１〕辛基－２－羥基苯甲醯胺化合物

Also Published As

Publication number Publication date
EP2001876A2 (en) 2008-12-17
DK2001876T3 (da) 2011-08-29
KR101376479B1 (ko) 2014-03-27
MX2008011165A (es) 2008-09-15
CA2646409C (en) 2015-11-10
US20190119267A1 (en) 2019-04-25
US10745394B2 (en) 2020-08-18
SI2001876T1 (sl) 2011-09-30
US20140288112A1 (en) 2014-09-25
BRPI0708490B8 (pt) 2021-05-25
NZ570764A (en) 2011-08-26
CY1111747T1 (el) 2015-10-07
US8664242B2 (en) 2014-03-04
RU2008138875A (ru) 2010-04-10
US20170349578A1 (en) 2017-12-07
ATE509928T1 (de) 2011-06-15
TWI379832B (en) 2012-12-21
RU2423362C2 (ru) 2011-07-10
US9206172B2 (en) 2015-12-08
TW200800981A (en) 2008-01-01
MY145633A (en) 2012-03-15
KR20080100282A (ko) 2008-11-14
PT2001876E (pt) 2011-08-18
US8263618B2 (en) 2012-09-11
HRP20110590T1 (hr) 2011-09-30
BRPI0708490B1 (pt) 2019-07-30
US20160176863A1 (en) 2016-06-23
HK1125935A1 (en) 2009-08-21
US10081626B2 (en) 2018-09-25
JP5086280B2 (ja) 2012-11-28
US20130158060A1 (en) 2013-06-20
AU2007224213B2 (en) 2012-06-14
US20230183232A1 (en) 2023-06-15
US7622508B2 (en) 2009-11-24
US11548887B2 (en) 2023-01-10
US20190308966A1 (en) 2019-10-10
BRPI0708490A2 (pt) 2011-05-31
AR059690A1 (es) 2008-04-23
IL193690A0 (en) 2009-08-03
JP2009528371A (ja) 2009-08-06
MA30284B1 (fr) 2009-03-02
CA2646409A1 (en) 2007-09-13
US20210024515A1 (en) 2021-01-28
PL2001876T3 (pl) 2011-10-31
US10377751B2 (en) 2019-08-13
US20100035921A1 (en) 2010-02-11
WO2007103187A2 (en) 2007-09-13
IL193690A (en) 2013-02-28
EP2001876B1 (en) 2011-05-18
JP2012211193A (ja) 2012-11-01
AU2007224213A1 (en) 2007-09-13
US9663509B2 (en) 2017-05-30
US20150291579A1 (en) 2015-10-15
US20070219278A1 (en) 2007-09-20
WO2007103187A3 (en) 2007-11-01
US8927573B2 (en) 2015-01-06

Similar Documents

Publication Publication Date Title
PE20071311A1 (es) Compuestos 8-azabiciclo[3.2.1]octano como antagonistas del receptor opioide mu
PE20081887A1 (es) Nuevo compuesto de adenina
PE20081776A1 (es) Moduladores 2-aminopirimidina del receptor histamina h4
PE20091562A1 (es) Derivados de naftiridinona como inhibidores de cinasa y composiciones que los comprenden
ECSP088820A (es) Síntesis de acil-amino-alquenilen-amidas utiles como antagonistas de la sustancia p.
PE20091561A1 (es) Compuestos inhibidores de raf y metodos para su uso
CR9459A (es) Derivados benzodioxano y benzodioxolano y usos de los mismos
DOP2010000192A (es) Compuestos de carbamoilo como inhibidores de dgat1 190
MX2009005461A (es) N-oxidos de analogos de 4,5-epoxi-morfinano.
PE20080263A1 (es) Compuestos de pirrolo-pirimidina y sus usos
HK1120442A1 (en) Novel opioid antagonists
PE20091100A1 (es) Nuevos compuestos 010
AR064735A1 (es) Agonistas de gpcr y composicion farmaceutica en base al compuesto
PE20141205A1 (es) Spiro-[1,3]-oxacinas y spiro-[1,4]-oxacepinas como inhibidores de bace1 y/o bace2
CO6220949A2 (es) Derivados pirazolicos como inhibidores de la 11 beta -hsd1
PE20141203A1 (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
GT200600165A (es) Derivados dihidrobenzofuranos y usos de los mismos
AR076460A1 (es) Antagonistas del receptor cxcr3
GT200600030A (es) 2-fenil-indoles como antagonistas del receptor de la prostaglandina d2
TW201129565A (en) Tricyclic heterocyclic compounds, compositions and methods of use thereof
PE20110150A1 (es) Amidofenoxiindazoles como inhibidores de c-met
PE20110296A1 (es) Compuestos heterociclicos fusionados como moduladores del receptor de orexina
DE602006006850D1 (de) Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate
PE20070016A1 (es) Compuestos heterociclicos n-enlazados como antagonistas del receptor p2y1

Legal Events

Date Code Title Description
FG Grant, registration